US 7378093
Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus selected by Env-CD4-co-receptor complexes
granted A61KA61K2039/505A61P
Quick answer
US patent 7378093 (Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus selected by Env-CD4-co-receptor complexes) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61P, A61P31/14, A61P31/18